EOL©, an e-CRF solution for clinical studies and randomization

EOL© a solution adapted to your profile

French version English version
Customer area Validate
password forgotten
RSS feed print the page make the site known

Public References

Since its creation, MEDSHARING provides the public sector with solutions tailored to its specific characteristics.

EOL© is used in many studies and registries in various therapeutic areas.

To date more than 40 studies have been conducted for the public sector for the recruitment of 300 to over 5000 patients, in oncology, digestive surgery, cardiology and neurology.

MEDSHARING is present in UHs and research units in France, Belgium and Germany.

We can, upon request, organise an exchange with our public customers to enable you to assess EOL© with your colleagues.


Some significant studies:

  • National Network for the Study of Predictors and Prevention of Sudden Unexpected Deaths in drug-resistant partial epilepsy.

  • Randomised trial comparing the internal jugular and femoral catheterisation in terms of iatrogenic, nosocomial complications and quality of dialysis in intensive care in the ERA.

  • Comparison of pelvic lymphadenectomy with isolated sample from the sentinel node in early cervical cancer: randomised multicentre study with assessment of medical-economic impacts.



they trust us

animated logos for our customers

Our news

EOL New brochure available!
March 2016 : EOL the new brochure is available!

Medsharing in figures
(Figures 2015)
78,000 patients since 2003 for over 130 studies.
  
26 Registries / Observatories.
49 Studies.
61 Clinical Trials
31 Randomizations (without eCRF)

47 Drug Studies
28 DM Studies

66 Ongoing studies.

Figures 2015


New version of the application of randomization
Check out the new unlimited version of our Randomization for clinical trial application IPHONE / IPAD.

Contact Medsharing

+33 (0)1 48 75 39 14
by e-mail

Subscribe to the newsletter

top logo Medsharing

by Neuro-Graph

June 2017

close the window
password forgotten ?